Le Querrec A - Search Results

1

In vivo biological effects of foam sclerotherapy.

Hamel-Desnos CM, Desnos PR, Ferre B, Le Querrec A. Hamel-Desnos CM, et al. Among authors: le querrec a. Eur J Vasc Endovasc Surg. 2011 Aug;42(2):238-45. doi: 10.1016/j.ejvs.2011.03.034. Epub 2011 Apr 30. Eur J Vasc Endovasc Surg. 2011. PMID: 21531587 Free article. Clinical Trial.

2

Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis.

Roule V, Ardouin P, Repessé Y, Le Querrec A, Blanchart K, Lemaitre A, Sabatier R, Borel-Derlon A, Beygui F. Roule V, et al. Among authors: le querrec a. Clin Appl Thromb Hemost. 2018 Oct;24(7):1109-1116. doi: 10.1177/1076029618772354. Epub 2018 May 2. Clin Appl Thromb Hemost. 2018. PMID: 29719963 Free PMC article.

3

[Guidelines for certification of International Normalized Ratio (INR) for vitamin K antagonists monitoring according to the EN ISO 22870 standards].

Brionne-François M, Bauters A, Mouton C, Voisin S, Flaujac C, Le Querrec A, Lasne D. Brionne-François M, et al. Among authors: le querrec a. Ann Biol Clin (Paris). 2018 Jun 1;76(3):271-299. doi: 10.1684/abc.2018.1332. Ann Biol Clin (Paris). 2018. PMID: 29701179 Free article. French.

4

[Near-patient testing devices to monitor vitamin K antagonists].

Brionne-Francois M, Le Querrec A, Lasne D. Brionne-Francois M, et al. Among authors: le querrec a. Ann Biol Clin (Paris). 2013 Nov;71:59-69. doi: 10.1684/abc.2013.0904. Ann Biol Clin (Paris). 2013. PMID: 24235329 Review. French.

5

Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies.

Le Querrec A, Arnout J, Arnoux D, Borg JY, Caron C, Darnige L, Delahousse B, Reber G, Sié P. Le Querrec A, et al. Thromb Haemost. 2001 Aug;86(2):584-9. Thromb Haemost. 2001. PMID: 11522007

6

[Mesentric venous thrombosis. Risk factors, treatment and outcome. An analysis of 18 cases].

Lefrançois C, Derlon A, Le Querrec A, Justum AM, Gautier P, Maurel J, Leroux Y, Lochu T, Sillard B, Deshayes JP, et al. Lefrançois C, et al. Among authors: le querrec a. Ann Fr Anesth Reanim. 1994;13(2):182-94. doi: 10.1016/s0750-7658(05)80551-9. Ann Fr Anesth Reanim. 1994. PMID: 7818202 Review. French.

7

[Activated thromboplastin time, plasma heparin and plasma fibrinogen using the Fibrintimer 10].

Khayat MC, Laforet F, Khayat A, Derlon A, Lequerrec A, Thomas M. Khayat MC, et al. Ann Biol Clin (Paris). 1988;46(8):696-700. Ann Biol Clin (Paris). 1988. PMID: 3218791 French.

8

[Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].

Barjot P, Beucher G, Le Querrec A, Derlon-Borel A, Herlicoviez M. Barjot P, et al. Among authors: le querrec a. J Gynecol Obstet Biol Reprod (Paris). 1999 Oct;28(6):544-9. J Gynecol Obstet Biol Reprod (Paris). 1999. PMID: 10598348 French.

9

[Guidelines for certification of Activated clotting time (ACT) according to the EN ISO 22870 standards].

Lasne D, Bauters A, Le Querrec A, Bourdin C, Voisin S; Societe Francaise de Biologie Clinique (SFBC); Groupe d'Etude d'Hemostase et Thrombose (GEHT). Lasne D, et al. Among authors: le querrec a. Ann Biol Clin (Paris). 2015 Mar-Apr;73(2):225-54. doi: 10.1684/abc.2015.1035. Ann Biol Clin (Paris). 2015. PMID: 25847747 Free article. French.

10

Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.

Emmerich J, Alhenc-Gelas M, Aillaud MF, Juhan-Vague I, Jude B, Garcin JM, Dreyfus M, de Moerloose P, Le Querrec A, Priollet P, Berruyer M, Vallantin X, Wolf M, Aiach M, Fiessinger JN. Emmerich J, et al. Among authors: le querrec a. Thromb Haemost. 1997 Apr;77(4):620-3. Thromb Haemost. 1997. PMID: 9134631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results